The Role Of Pomalidomide-Dexamethasone In Patients With Multiple Myeloma

The role of pomalidomide-dexamethasone in patients with multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Real-world safety & efficacy of isatuximab-pomalidomide-dexamethasone in R/R multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Elotuzumab Plus Pomalidomide and Dexamethasone for Multiple Myeloma

Ixazomib Plus Pomalidomide, Dexamethasone in Relapsed/Refractory Myeloma

American Society of Hematology

Elotuzumab, pomalidomide, and dexamethasone for advanced myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Pomalidomide with dexamethasone in relapsed/refractory multiple myeloma with renal impairment

VJHemOnc – Video Journal of Hematology & HemOnc

Pomalidomide in Multiple Myeloma

Triplet Regimens With Pomalidomide in Patients With Multiple Myeloma

Targeted Oncology

Bispecific Antibodies in Multiple Myeloma

International Academy for Clinical Hematology IACH

Using Pomalidomide in Multiple Myeloma

Pomalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma

UK practice: pomalidomide in patients resistant to lenalidomide

VJHemOnc – Video Journal of Hematology & HemOnc

Pomalidomide in Refractory Multiple Myeloma

Pomalidomide plus dexamethasone for R/R multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Voorhees on Pomalidomide/Dexamethasone/Ixazomib Triplet in Multiple Myeloma

Pomalidomide in multiple myeloma - Video abstract ID 115456

Dove Medical Press

Phase III study of isatuximab, pomalidomide, and low-dose dexamethasone in pts with RRMM

International Myeloma Foundation

Clinical Rationale for Pomalidomide in Myeloma

Targeted Oncology

Dr. Siegel on Pomalidomide in Lenalidomide-Refractory Patients With Myeloma

Daratumumab + Pomalidomide & Dexamethasone Effective in Relapsed/Refractory Multiple Myeloma